Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections
This study has been completed.
Study NCT00948142   Information provided by Cempra Pharmaceuticals

First Received on July 28, 2009.   Last Updated on September 15, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Skin Diseases, Bacterial
Additional conditions recognized in this trial
Skin Diseases
Skin Diseases, Infectious
More general conditions related to this trial
Bacterial Infections
Infection
Interventions listed in this trial
CEM-102
Linezolid
Additional drug interventions recognized in this trial
Fusidic Acid
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Cempra Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services